Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [Yahoo! Finance]
Aytu BioPharma, Inc. (AYTU)
NASDAQ:AMEX Investor Relations:
aytubio.com/investors/stock-information
Company Research
Source: Yahoo! Finance
Aytu BioPharma Inc ( NASDAQ:AYTU ) reported its first quarter with positive net income in the company's history. The company achieved its sixth consecutive quarter of positive adjusted EBITDA. ADHD script levels are above normalized trend lines, indicating growth in the ADHD portfolio. The pediatric portfolio saw its first sequential revenue growth in the last five quarters. Organizational changes are expected to reduce operating expenses by at least $2 million annually. Net revenue decreased to $16.6 million from $17.8 million in the year-ago quarter. Pediatric revenue was down to $1.3 million from $2.6 million compared to the previous year. Gross margin slightly decreased to 72% from 73% in the previous year. There is expected noise in gross margins for the next several quarters due to inventory costs. The company is still recovering from the impact of payer changes on its pediatric brands. Warning! GuruFocus has detected 3 Warning Signs with AYTU. Q : On the
Show less
Read more
Impact Snapshot
Event Time:
AYTU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AYTU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AYTU alerts
High impacting Aytu BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
AYTU
News
- Attention Deficit Hyperactivity Disorder Market to hit USD 24.6 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Disclosure Notification [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma Disclosure NotificationAccesswire
- Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]Yahoo! Finance
AYTU
Sec Filings
- 12/4/24 - Form 8-K
- 11/13/24 - Form SC
- 11/13/24 - Form 10-Q
- AYTU's page on the SEC website